Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, announces that the first two patients have been treated in the company’s Phase I/II clinical trial. The trial investigates the safety and tolerability of a new, tailored treatment for advanced colorectal cancer, a disease with significant medical needs …
